WHOCC
Postal address:
WHO Collaborating Centre for Drug Statistics Methodology
Norwegian Institute of Public Health
Postboks 222 Sk°yen
0213 Oslo
Norway

Visiting/delivery address:
Myrens verksted 6H
0473 Oslo
Norway

Tel:  +47 21 07 81 60
E-mail:
 
Copyright/Disclaimer

New search    Hide text from Guidelines

C CARDIOVASCULAR SYSTEM

This group comprises substances used for the treatment of cardiovascular conditions.
Drugs used for the treatment of hypertension are classified in C02 - Antihypertensives, C03 - Diuretics, C07 - Beta blocking agents, C08 - Calcium channel blockers, and C09 - Agents acting on the renin-angiotensin system. For the classification of combination products of antihypertensives from different ATC groups, the following ranking should be used, from higher to lower precedence: C09, C07, C08, , and C03.


C05 VASOPROTECTIVES

No DDDs are established in this group, since most of the drugs in this group are for topical use.


C05C CAPILLARY STABILIZING AGENTS

C05CA Bioflavonoids

Rutoside is classified in this group.
Oxerutines are classified in C05CA54.
Combinations with other capillary stabilizing agents are classified at separate 5th levels using the corresponding 50-series.

C05CX Other capillary stabilizing agents

Lysine aescinate is classified in C05CX03.

Last updated: 2023-01-23